Integrated Wealth Concepts’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138K Hold
45,200
﹤0.01% 2281
2026
Q1
$126K Sell
45,200
-5,800
-11% -$19.7K ﹤0.01% 2157
2025
Q4
$187K Sell
51,000
-17,000
-25% -$48.4K ﹤0.01% 1539
2025
Q3
$251K Hold
68,000
﹤0.01% 1736
2025
Q2
$126K Buy
68,000
+8,600
+14% +$14.9K ﹤0.01% 1811
2025
Q1
$92.7K Hold
59,400
﹤0.01% 1680
2024
Q4
$120K Buy
59,400
+13,300
+29% +$24.1K ﹤0.01% 1647
2024
Q3
$66.6K Buy
46,100
+18,700
+68% +$35.6K ﹤0.01% 1631
2024
Q2
$46.9K Buy
27,400
+7,334
+37% +$13.3K ﹤0.01% 1616
2024
Q1
$40.1K Buy
20,066
+10,000
+99% +$19.9K ﹤0.01% 1623
2023
Q4
$30.3K Buy
+10,066
New +$26.6K ﹤0.01% 1573

Other funds holding FBIO

Integrated Wealth Concepts's FBIO Position: Q2 2026 in Review

Integrated Wealth Concepts held its Fortress Biotech (FBIO) position steady in Q2 2026 at 45,200 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #2281.

Integrated Wealth Concepts first reported a position in FBIO in Q4 2023 and has held it in 11 quarters since. The position peaked at $251K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Integrated Wealth Concepts held 45,200 shares of Fortress Biotech worth $138K as of Q2 2026.
  • Integrated Wealth Concepts left its Fortress Biotech share count unchanged in Q2 2026.
  • Fortress Biotech made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #2281 holding.
  • Integrated Wealth Concepts first reported a position in Fortress Biotech in Q4 2023 and has held it in 11 quarters since.
  • Integrated Wealth Concepts's Fortress Biotech position peaked at $251K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.